Suzetrigine (VX-548): Bidding goodbye to opioids: The latest oral non-opioid analgesic for acute pain
Suzetrigine is the first and only FDA-approved non-opioid oral medication designed to be used for the treatment of moderate-to-severe acute pain. It represents a significant step forward in pain treatment by providing excellent relief without the hazards associated with opiate usage. Its approval tr...
Saved in:
| Main Authors: | Konica Chittoria, Ankur Sharma, Nikhil Kothari, Kamlesh Kumari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Saudi Journal of Anaesthesia |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/sja.sja_366_25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opioid analgesics: Managing the predictable
by: A Barnes, et al.
Published: (2025-07-01) -
Breaking the pain barrier: how suzetrigine and selective sodium channel blockers are reshaping the future of opioid-free analgesia
by: Aleksandra Kaniak, et al.
Published: (2025-06-01) -
Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain
by: Jeremiah D. Osteen, et al.
Published: (2025-01-01) -
Multimodal Analgesia in Cardiothoracic Procedure: Opioid and Non-opioid Pharmacology for Pain Management: Part 1
by: Himani V. Bhatt, et al.
Published: (2025-07-01) -
Analgesia postoperatoria libre de opioids ¿En cuáles pacientes deberíamos usarla y cuáles fármacos usar?: una revisión sistemática
by: Marcos Bolívar, et al.
Published: (2024-03-01)